BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
86 results:

  • 1. Identification of crucial genes involved in thyroid cancer development.
    Kalarani IB; Sivamani G; Veerabathiran R
    J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancer.
    La Marca JE; Ely RW; Diepstraten ST; Burke P; Kelly GL; Humbert PO; Richardson HE
    Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36861754
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
    Amran N; Abdul-Rahman PS
    J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The role of TBK1 in cancer pathogenesis and anticancer immunity.
    Runde AP; Mack R; S J PB; Zhang J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rapid Detection of n-ras Gene Common Mutations in Acute Myeloid leukemia (AML) Using High Resolution Melting (HRM) Method.
    Zaka Khosravi S; Moonesi M; Moradabadi A; Rajaeinejad M; Heidari MF; Noroozi-Aghideh A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):125-130. PubMed ID: 35092380
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vitexin isolated from Prosopis cineraria leaves induce apoptosis in K-562 leukemia cells via inhibition of the BCR-ABL-Ras-Raf pathway.
    Sarkar MK; Kar A; Jayaraman A; Kar Mahapatra S; Vadivel V
    J Pharm Pharmacol; 2022 Jan; 74(1):103-111. PubMed ID: 34109977
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.
    Guillon J; Denevault-Sabourin C; Chevret E; Brachet-Botineau M; Milano V; Guédin-Beaurepaire A; Moreau S; Ronga L; Savrimoutou S; Rubio S; Ferrer J; Lamarche J; Mergny JL; Viaud-Massuard MC; Ranz M; Largy E; Gabelica V; Rosu F; Gouilleux F; Desplat V
    Arch Pharm (Weinheim); 2021 Aug; 354(8):e2000450. PubMed ID: 33852185
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products.
    Silva LR; da Silva-Júnior EF
    Curr Med Chem; 2022; 29(2):189-211. PubMed ID: 33719954
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
    Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
    [No Abstract]    [Full Text] [Related]  

  • 13. Atypical Chronic Myeloid leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
    Wu HT; Liu YE; Hsu KW; Wang YF; Chan YC; Chen Y; Chen DR
    Am J Chin Med; 2020; 48(5):1221-1241. PubMed ID: 32668964
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-leukemia Effect.
    Choi EY; Choi K; Nam G; Kim W; Chung M
    Front Immunol; 2020; 11():1163. PubMed ID: 32587590
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.
    Ronsley R; Kariminia A; Ng B; Mostafavi S; Reid G; Subrt P; Hijiya N; Schultz KR
    Pediatr Hematol Oncol; 2019 Nov; 36(8):468-481. PubMed ID: 31530240
    [No Abstract]    [Full Text] [Related]  

  • 17. Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.
    Sakakibara K; Tsujioka T; Kida JI; Kurozumi N; Nakahara T; Suemori SI; Kitanaka A; Arao Y; Tohyama K
    Int J Hematol; 2019 Aug; 110(2):213-227. PubMed ID: 31129802
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
    Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
    Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Wogonoside induces depalmitoylation and translocation of PLSCR1 and n-ras in primary acute myeloid leukaemia cells.
    Li H; Yu X; Liu X; Hu P; Shen L; Zhou Y; Zhu Y; Li Z; Hui H; Guo Q; Xu J
    J Cell Mol Med; 2018 Apr; 22(4):2117-2130. PubMed ID: 29377576
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. T cell leukemia control via Ras-Raf pathway inhibition with peptides.
    Marin GH; Rebollo A; Bruzzoni-Giovanelli H; Schinella G; Piazzon I; Duarte A; Errecalde J
    J Med Life; 2017; 10(3):172-175. PubMed ID: 29075346
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.